Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Zelira Therapeutics.
RELATED STOCKHEAD STORIES
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Compumedics wins FDA approval for its brain scanners, leaps +20pc
News
Lunchtime ASX small cap wrap: Who’s getting locked in a stalemate today?
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Cannabis: Elixinol Global kills medical pot, holds fire sale for Aussie hemp
Health & Biotech
My bank balance is bigger than yours: biotech quarterlies
Health & Biotech
NT pot scripts stand at 1 as industry begs govt to act on patient access
Health & Biotech
The US legal pot market is massive and confusing: report
Health & Biotech
Biotech: Cynata wins first round against sepsis bugs
Health & Biotech
Cannabis: THC Global hits milestone with first cannabis production at Southport
Health & Biotech
Weed Week: Wait till cannabis is legalised federally in the US – big pharma are already dreading it
Health & Biotech
Health: China loves Aussie food, maybe next it’ll love MVP’s Green Whistle too
Health & Biotech
Weed Week: In Thailand you’ll be able to grow cannabis ‘like any other herb’
Health & Biotech
With M&A heating up in Aus cannabis, is it international land grab time?
Health & Biotech
The life sciences investment wave is building. Here’s how to ride it.
Health & Biotech
“We’re creating something the world doesn’t have”: Zelda boss on US merger
Health & Biotech